Viatris Dishes On Insulin Aspart Biosimilar As Key Date Passes

Company Won Landmark Interchangeable Insulin Glargine Approval In July

 
• By Dean Rudge
  
FDABldg1ExteriorWithCircle_1200x675
Viatris/Biocon's insulin aspart has been approved in the EU • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products